Physician profile
Angela Carol Carter
NPI 1457551525
$1,217.58
in general payments reported to CMS, 2019-2025
13 companies · $302 in 2025
The $302 reported for 2025 was more than what 95% of Neonatal (Nurse Practitioner) providers received nationally (typical 2025 total: $40.24).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $60.66 · 2022: $41.78 · 2023: $190 · 2024: $623 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $476.24 | 2024-2025 | Wegovy |
| Abbott Laboratories | $171.08 | 2023 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $122.49 | 2024 | Austedo Xr |
| Astrazeneca Pharmaceuticals Lp | $119.84 | 2024 | Airsupra |
| Novartis Pharmaceuticals Corporation | $116.97 | 2024 | |
| Sanofi Pasteur INC. | $63.14 | 2024-2025 | |
| Corium, LLC | $32.88 | 2022-2023 | Azstarys |
| Biohaven Pharmaceuticals, INC. | $31.01 | 2021 | |
| Supernus Pharmaceuticals, INC. | $26.30 | 2025 | Qelbree |
| Lilly USA, LLC | $15.70 | 2021 | |
| Sobi, INC | $15.07 | 2022 | |
| Eisai INC. | $13.95 | 2021 | |
| Glaxosmithkline, LLC. | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.